Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer
- Thursday, January 12, 2023, 7:05
- Finance
- Add a comment
DUBLIN, Jan. 12, 2023 /PRNewswire/ — Mallinckrodt plc (NYSE American: MNK) (“Mallinckrodt” or the “Company”), a global specialty pharmaceutical company, today announced that Dr. Peter Richardson, B.Med.Sci., BM, BS, MRCP (UK) has been appointed Executive Vice President and Chief…
About the Author
adminasapcorp has written 41562 stories on this site.